1,2-dimethylhydrazine decreases expression ISO RGD:1316783 6480464 1, 2-Dimethylhydrazine results in decreased expression of IFNGR2 mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316783 6480464 Tetrachlorodibenzodioxin affects the expression of IFNGR2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IFNGR2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1316783 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IFNGR2 mRNA CTD PMID:25975270 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of IFNGR2 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1316783 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of IFNGR2 mRNA CTD PMID:20188158 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:1316783 6480464 Oxazolone results in decreased expression of IFNGR2 mRNA CTD PMID:21404309 acrolein increases expression ISO RGD:1316783 6480464 Acrolein results in increased expression of IFNGR2 mRNA CTD PMID:18515264 acrolein multiple interactions ISO RGD:1316782 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IFNGR2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of IFNGR2 mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO RGD:1316783 6480464 Aflatoxin B1 results in increased expression of IFNGR2 mRNA CTD PMID:19770486 Aflatoxin B2 alpha decreases methylation ISO RGD:1316782 6480464 aflatoxin B2 results in decreased methylation of IFNGR2 promoter CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1316782 6480464 Tretinoin results in increased expression of IFNGR2 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1316782 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IFNGR2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of IFNGR2 mRNA CTD PMID:32699268 antirheumatic drug decreases expression ISO RGD:1316782 6480464 Antirheumatic Agents results in decreased expression of IFNGR2 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1316782 6480464 Arsenic affects the methylation of IFNGR2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1316782 6480464 Arsenic affects the methylation of IFNGR2 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:1316782 6480464 Arsenic Trioxide results in increased expression of IFNGR2 mRNA CTD PMID:29633893 benzene increases expression ISO RGD:1316782 6480464 Benzene results in increased expression of IFNGR2 mRNA CTD PMID:20359517 benzo[a]pyrene decreases expression ISO RGD:1316783 6480464 Benzo(a)pyrene results in decreased expression of IFNGR2 mRNA CTD PMID:21569818 benzo[a]pyrene decreases methylation ISO RGD:1316782 6480464 Benzo(a)pyrene results in decreased methylation of IFNGR2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1316783 6480464 Benzo(a)pyrene results in increased expression of IFNGR2 mRNA CTD PMID:22228805 benzo[e]pyrene increases methylation ISO RGD:1316782 6480464 benzo(e)pyrene results in increased methylation of IFNGR2 intron CTD PMID:30157460 benzo[e]pyrene decreases methylation ISO RGD:1316782 6480464 benzo(e)pyrene results in decreased methylation of IFNGR2 promoter CTD PMID:30157460 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IFNGR2 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1316782 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of IFNGR2 gene CTD PMID:31601247 cadmium selenide multiple interactions ISO RGD:1316782 6480464 [cadmium selenide co-treated with zinc sulfide] results in increased expression of IFNGR2 mRNA CTD PMID:22342292 cannabidiol decreases expression ISO RGD:1316782 6480464 Cannabidiol results in decreased expression of IFNGR2 mRNA CTD PMID:27932991 chloropicrin decreases expression ISO RGD:1316782 6480464 chloropicrin results in decreased expression of IFNGR2 mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:1316783 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of IFNGR2, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IFNGR2 gene CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1316783 6480464 chromium hexavalent ion affects the expression of IFNGR2 mRNA CTD PMID:28472532 copper atom multiple interactions ISO RGD:1316782 6480464 [Disulfiram binds to Copper] which results in increased expression of IFNGR2 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:1316782 6480464 [Disulfiram binds to Copper] which results in increased expression of IFNGR2 mRNA CTD PMID:24690739 copper(II) sulfate increases expression ISO RGD:1316782 6480464 Copper Sulfate results in increased expression of IFNGR2 mRNA CTD PMID:19549813 crocidolite asbestos affects expression ISO RGD:1316782 6480464 Asbestos, Crocidolite affects the expression of IFNGR2 mRNA CTD PMID:24160326 diarsenic trioxide increases expression ISO RGD:1316782 6480464 Arsenic Trioxide results in increased expression of IFNGR2 mRNA CTD PMID:29633893 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of IFNGR2 mRNA CTD PMID:21266533 dichloromethane increases expression ISO RGD:1316782 6480464 Methylene Chloride results in increased expression of IFNGR2 mRNA CTD PMID:20359517 disulfiram multiple interactions ISO RGD:1316782 6480464 [Disulfiram binds to Copper] which results in increased expression of IFNGR2 mRNA CTD PMID:24690739 diuron decreases expression EXP 6480464 Diuron results in decreased expression of IFNGR2 mRNA CTD PMID:21551480 doxorubicin decreases expression ISO RGD:1316783 6480464 Doxorubicin results in decreased expression of IFNGR2 mRNA CTD PMID:21040762 doxorubicin decreases expression ISO RGD:1316782 6480464 Doxorubicin results in decreased expression of IFNGR2 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:1316783 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of IFNGR2 mRNA CTD PMID:21040762 ethylbenzene increases expression ISO RGD:1316782 6480464 ethylbenzene results in increased expression of IFNGR2 mRNA CTD PMID:20359517 folic acid multiple interactions ISO RGD:1316783 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of IFNGR2, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IFNGR2 gene CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:1316782 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of IFNGR2 gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of IFNGR2 mRNA CTD PMID:22061828 ionomycin multiple interactions ISO RGD:1316782 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNGR2 mRNA, pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNGR2 mRNA] CTD PMID:15477007 isoprenaline decreases expression ISO RGD:1316783 6480464 Isoproterenol results in decreased expression of IFNGR2 mRNA CTD PMID:20003209 ketamine increases expression EXP 6480464 Ketamine results in increased expression of IFNGR2 mRNA CTD PMID:20080153 L-methionine multiple interactions ISO RGD:1316783 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of IFNGR2, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IFNGR2 gene CTD PMID:20938992 lipopolysaccharide increases expression ISO RGD:1316783 6480464 Lipopolysaccharides results in increased expression of IFNGR2 mRNA CTD PMID:12057914 , PMID:15919760 methapyrilene increases methylation ISO RGD:1316782 6480464 Methapyrilene results in increased methylation of IFNGR2 intron CTD PMID:30157460 methapyrilene decreases methylation ISO RGD:1316782 6480464 Methapyrilene results in decreased methylation of IFNGR2 promoter CTD PMID:30157460 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of IFNGR2 gene CTD PMID:23303685 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:1316782 6480464 N more ... CTD PMID:12756304 nickel dichloride increases expression ISO RGD:1316782 6480464 nickel chloride results in increased expression of IFNGR2 mRNA CTD PMID:17312168 o-xylene increases expression ISO RGD:1316782 6480464 2-xylene results in increased expression of IFNGR2 mRNA CTD PMID:20359517 ozone multiple interactions ISO RGD:1316782 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IFNGR2 mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RGD:1316782 6480464 Acetaminophen results in decreased expression of IFNGR2 mRNA CTD PMID:21420995 phenytoin increases expression ISO RGD:1316782 6480464 Phenytoin results in increased expression of IFNGR2 mRNA CTD PMID:14741686 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1316782 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNGR2 mRNA, pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNGR2 mRNA] CTD PMID:15477007 pirinixic acid increases expression ISO RGD:1316783 6480464 pirinixic acid results in increased expression of IFNGR2 mRNA CTD PMID:18301758 , PMID:23811191 pyrrolidine dithiocarbamate multiple interactions ISO RGD:1316782 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNGR2 mRNA] CTD PMID:15477007 quercetin decreases expression ISO RGD:1316782 6480464 Quercetin results in decreased expression of IFNGR2 mRNA CTD PMID:15309432 raloxifene multiple interactions ISO RGD:1316782 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of IFNGR2 mRNA CTD PMID:19059307 serpentine asbestos affects expression ISO RGD:1316782 6480464 Asbestos, Serpentine affects the expression of IFNGR2 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO RGD:1316783 6480464 Silicon Dioxide results in increased expression of IFNGR2 mRNA CTD PMID:23221170 silver atom decreases expression ISO RGD:1316783 6480464 Silver results in decreased expression of IFNGR2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1316783 6480464 Silver results in decreased expression of IFNGR2 mRNA CTD PMID:27131904 sunitinib decreases expression ISO RGD:1316782 6480464 Sunitinib results in decreased expression of IFNGR2 mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO RGD:1316782 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of IFNGR2 mRNA CTD PMID:19059307 testosterone decreases expression ISO RGD:1316783 6480464 Testosterone results in decreased expression of IFNGR2 mRNA CTD PMID:20403060 tetrachloroethene increases expression ISO RGD:1316783 6480464 Tetrachloroethylene results in increased expression of IFNGR2 mRNA CTD PMID:28973375 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IFNGR2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1316782 6480464 titanium dioxide results in increased expression of IFNGR2 mRNA CTD PMID:22342292 titanium dioxide increases expression ISO RGD:1316783 6480464 titanium dioxide analog results in increased expression of IFNGR2 mRNA, titanium dioxide results in increased expression of IFNGR2 mRNA CTD PMID:23557971 , PMID:25111187 toluene increases expression ISO RGD:1316782 6480464 Toluene results in increased expression of IFNGR2 mRNA CTD PMID:20359517 toluene 2,4-diisocyanate increases expression ISO RGD:1316783 6480464 Toluene 2, 4-Diisocyanate results in increased expression of IFNGR2 mRNA CTD PMID:19647056 toluene 2,4-diisocyanate decreases expression ISO RGD:1316783 6480464 Toluene 2, 4-Diisocyanate results in decreased expression of IFNGR2 mRNA CTD PMID:21404309 trichloroethene increases expression ISO RGD:1316782 6480464 Trichloroethylene results in increased expression of IFNGR2 mRNA CTD PMID:20359517 trichostatin A affects expression ISO RGD:1316782 6480464 trichostatin A affects the expression of IFNGR2 mRNA CTD PMID:28542535 valproic acid increases methylation ISO RGD:1316782 6480464 Valproic Acid results in increased methylation of IFNGR2 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1316782 6480464 Valproic Acid results in decreased expression of IFNGR2 mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:1316782 6480464 Valproic Acid affects the expression of IFNGR2 mRNA CTD PMID:25979313
